A2A Pharmaceuticals

A2A designs novel pre-optimized therapeutics for cancer and infectious disease using proprietary software. Data from in-vitro leukemia testing is very good.

  • Stage Product In Development
  • Industry Biotechnology
  • Location San Francisco, CA, US
  • Currency USD
  • Founded April 2016
  • Employees 2
  • Incorporation Type C-corp
  • Website A2Apharma.com

Company Summary

A2A has designed pre-optimized new drug candidates for leukemia and other cancers as well as gram-negative bacterial infections. We are currently synthesizing and doing in-vitro testing. In-vitro results for the infant Leukemia candidate targeting MLL-Menin are very good. Multiple pharmaceutical companies have expressed an interest in partnering with A2A.

Team

Previous Investors

  • Indiebio
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free